{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:03:12Z","timestamp":1777442592595,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"no"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-015-0180-4","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T23:43:53Z","timestamp":1451951033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting"],"prefix":"10.1186","volume":"16","author":[{"given":"Andr\u00e9 Pacheco","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania Ogawa","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Gouveia","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Viviane","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Costa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Caleb Junior Lima","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"180_CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1211128","volume":"368","author":"P Jha","year":"2013","unstructured":"Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341\u201350. doi: 10.1056\/NEJMsa1211128 .","journal-title":"N Engl J Med"},{"key":"180_CR2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(11)60615-6","volume":"379","author":"S Glantz","year":"2012","unstructured":"Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet. 2012;379:1269\u201371. doi: 10.1016\/S0140-6736(11)60615-6 .","journal-title":"Lancet"},{"key":"180_CR3","unstructured":"Fiore MC, Ja\u00e9n CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update.Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. 2008."},{"key":"180_CR4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/14.12.1709","volume":"14","author":"A DaCosta","year":"1993","unstructured":"DaCosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, et al. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J. 1993;14:1709\u201311.","journal-title":"Eur Heart J"},{"key":"180_CR5","doi-asserted-by":"crossref","unstructured":"Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010; 8(1): 8. doi: 10.1186\/1617-9625-8-8 .","DOI":"10.1186\/1617-9625-8-8"},{"key":"180_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","volume":"129","author":"EJ Mills","year":"2014","unstructured":"Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014;129:28\u201341. doi: 10.1161\/CIRCULATIONAHA.113.003961 .","journal-title":"Circulation"},{"key":"180_CR7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","volume":"119","author":"NA Rigotti","year":"2006","unstructured":"Rigotti NA, Thorndike AN, Regan S, McKool K, Pasternak RC, Chang Y, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med. 2006;119:1080\u20137. doi: 10.1016\/j.amjmed.2006.04.024 .","journal-title":"Am J Med"},{"key":"180_CR8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","volume":"24","author":"S Tonstad","year":"2003","unstructured":"Tonstad S. Bupropion SR, for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J. 2003;24:946\u201355. doi: 10.1016\/S0195-668X(03)00003-4 .","journal-title":"Eur Heart J"},{"key":"180_CR9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacc.2012.08.1030","volume":"61","author":"MJ Eisenberg","year":"2013","unstructured":"Eisenberg MJ, Grandi SM, Gervais A, O\u2019Loughlin J, Paradis G, Rinfret S, et al. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2013;61:524\u201332. doi: 10.1016\/j.jacc.2012.08.1030 .","journal-title":"J Am Coll Cardiol"},{"key":"180_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","volume":"121","author":"NA Rigotti","year":"2010","unstructured":"Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121:221\u20139. doi: 10.1161\/CIRCULATIONAHA.109.869008 .","journal-title":"Circulation"},{"key":"180_CR11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1503\/cmaj.110218","volume":"183","author":"S Singh","year":"2011","unstructured":"Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183:1359\u201366. doi: 10.1503\/cmaj.110218 .","journal-title":"CMAJ"},{"key":"180_CR12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2856","volume":"344","author":"JJ Prochaska","year":"2012","unstructured":"Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344, e2856. doi: 10.1136\/bmj.e2856 .","journal-title":"BMJ"},{"issue":"6","key":"180_CR13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ntr\/nts230","volume":"15","author":"JS Issa","year":"2013","unstructured":"Issa JS, Abe TO, Moura S, Santos PCJL, Pereira AC. Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting. Nicotine Tob Res. 2013;15(6):1146\u201350. doi: 10.1093\/ntr\/nts230 .","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"180_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.2013.283185","volume":"311","author":"JO Ebbert","year":"2014","unstructured":"Ebbert JO, Hatsukami DK, Croghan IT, et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers. A randomized trial. JAMA. 2014;311(2):155\u201363. doi: 10.1001\/jama.2013.283185 .","journal-title":"JAMA"},{"issue":"11","key":"180_CR15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/appi.ajp.2014.13050595","volume":"171","author":"JE Rose","year":"2014","unstructured":"Rose JE, Behm FM. Combination varenicline\/bupropion treatment in an adaptative smoking cessation paradigm. Am J Psychiatry. 2014;171(11):1199\u2013205. doi: 10.1176\/appi.ajp.2014.13050595 .","journal-title":"Am J Psychiatry"},{"key":"180_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00846549","volume":"12","author":"KO Fagerstr\u00f6m","year":"1989","unstructured":"Fagerstr\u00f6m KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstr\u00f6m Tolerance Questionnaire. J Behav Med. 1989;12:159\u201382.","journal-title":"J Behav Med"},{"key":"180_CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S1806-37132012000600012","volume":"38","author":"JS Issa","year":"2012","unstructured":"Issa JS. A new nicotine dependence score and a new scale assessing patient comfort during smoking cessation treatment. J Bras Pneumol. 2012;38:761\u20135.","journal-title":"J Bras Pneumol"},{"key":"180_CR18","doi-asserted-by":"crossref","unstructured":"Issa JS, Abe TM, Pereira AC, Megid MC, Shimabukuro CE, Valentin LS, et al. The effect of S\u00e3o Paulo\u2019s smoke-free legislation on carbon monoxide concentration in hospitality venues and their workers. Tob Control. 2011;20:156\u201362. doi: 10.1136\/tc.2010.037614 .","DOI":"10.1136\/tc.2010.037614"},{"key":"180_CR19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.HYP.0000219284.47970.34","volume":"47","author":"B Najem","year":"2006","unstructured":"Najem B, Houssi\u00e8re A, Pathak A, Janssen C, Lemogoum D, Xha\u00ebt O, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension. 2006;47:1162\u20137. doi: 10.1161\/01.HYP.0000219284.47970.34 .","journal-title":"Hypertension"},{"key":"180_CR20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1524-6175.2005.04597.x","volume":"7","author":"JC Yugar-Toledo","year":"2005","unstructured":"Yugar-Toledo JC, Ferreira-Melo SE, Sabha M, Nogueira EA, Coelho OR, Consolin Colombo FM, et al. Blood Pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine. J Clin Hypertens (Greenwich). 2005;7:721\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"180_CR21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jash.2012.11.003","volume":"7","author":"DM Sobieraj","year":"2013","unstructured":"Sobieraj DM, White WB, Baker WL. Cardiovascular effects of pharmacologic therapies for smoking cessation. J Am Soc Hypertens. 2013;7:61\u20137. doi: 10.1016\/j.jash.2012.11.003 .","journal-title":"J Am Soc Hypertens"},{"key":"180_CR22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0149-2918(00)88301-0","volume":"21","author":"EC Settle","year":"1999","unstructured":"Settle EC, Stahl SM, Batey SR, Andrew Johnston J, Ascher JA. Safety profile of sustained-release bupropion in depression: Results of three clinical trials. Clin Ther. 1999;21:454\u201363. doi: 10.1016\/S0149-2918(00)88301-0 .","journal-title":"Clin Ther"},{"key":"180_CR23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0b013e318172424e","volume":"28","author":"ME Thase","year":"2008","unstructured":"Thase ME, Haight BR, Johnson MC, Hunt T, Krishen A, Fleck RJ, et al. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. J Clin Psychopharmacol. 2008;28:302\u20137. doi: 10.1097\/JCP.0b013e318172424e .","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 4","key":"180_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1067\/mhj.2000.109977","volume":"140","author":"SP Roose","year":"2000","unstructured":"Roose SP. Considerations for the use of antidepressants in patients with cardiovascular disease. Am Heart J. 2000;140 Suppl 4:84\u20138.","journal-title":"Am Heart J"},{"key":"180_CR25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","volume":"148","author":"SP Roose","year":"1991","unstructured":"Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry. 1991;148:512\u20136.","journal-title":"Am J Psychiatry"},{"key":"180_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","volume":"296","author":"S Tonstad","year":"2006","unstructured":"Tonstad S, T\u00f8nnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation. JAMA-EXPRESS. 2006;296:64\u201371.","journal-title":"JAMA-EXPRESS"},{"key":"180_CR27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0895-7061(01)01301-2","volume":"14","author":"JE Tanus-Santos","year":"2001","unstructured":"Tanus-Santos JE, Carlos J, Toledo Y. Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. Am J Hypertens. 2001;14:610\u20134.","journal-title":"Am J Hypertens"},{"key":"180_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-9236(98)90026-1","volume":"64","author":"S Zevin","year":"1998","unstructured":"Zevin S, Jacob P, Benowitz NL. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther. 1998;64:87\u201395. doi: 10.1016\/S0009-9236(98)90026-1 .","journal-title":"Clin Pharmacol Ther"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0180-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:00:06Z","timestamp":1498273206000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2261\/16\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1186\/s12872-015-0180-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,5]]},"article-number":"2"}}